RESEARCH —
THE BEST HOPE 
AGAINST CANCER.

We are Cancer Research Venture Philanthropists, making early investments in bold ideas in the fight against cancer. Help us fund tomorrow’s cancer game-changers today.

Learn More

01
Our Mission

IN 2018, 1,735,350 PEOPLE WILL BE DIAGNOSED WITH CANCER.

WE’RE HERE TO REDUCE CANCER DEATHS TO ZERO

Our mission is to raise funds to fund early-career cancer scientists and new directions in cancer science research with the goal of contributing to “Transformational Events” in the prevention, treatment and cure for cancer.

About Us

Home_Mission_Web

02
Our Research

FUNDING RISING STARS WITH BOLD NEW IDEAS.

Our goal is to fund tomorrow’s cancer game changers today. Over the years, the foundation has funded meaningful research resulting in progress and discoveries that have helped advance the fight against cancer. More than 180 researchers have been given the seed capital to launch their ideas in the fight against cancer.

Learn More

End of Year Giving

End of Year Giving

JOIN US FOR THE END OF YEAR GIVING SEASON.

This year, our goal is to fund ONE more Young Investigator through the Young Investigator Award Program. Each Young Investigator is awarded $75,000 to pursue their bold ideas in the search to find a cure for cancer.

Donate Now

Meet Jane Churpek.

Meet Jane Churpek.

SHE’S RESEARCHING INHERITED RISKS IN DEVELOPING BLOOD CANCERS.

Dr. Churpek will determine the proportion of inherited mutations in breast and ovarian cancer susceptibility genes in a cohort of women who developed therapy-related leukemias after being treated for breast or ovarian cancer. She established a unique cancer risk clinic focused on evaluating individuals at high risk of developing blood cancers.

Read More

Meet Lev Becker.

Meet Lev Becker.

HE’S RESEARCHING A NOVEL MECHANISM TO EXPLAIN HOW OBESITY INCREASES THE SEVERITY OF BREAST CANCER

The goal of his proposal is to deploy a specialized “stapled peptide” based on the BIM protein to uncover how DLBCL cells neutralize BIM and identify the exact molecular binding partners of this novel therapeutic within these cells.

Read More
Learn more

04
The Latest from CRF